Gene expression microarrays are an essential technology for the emerging discipline of pharmacogenomics, and the ways in which expression data are represented in computers have important implications for the analysis and communication of this new form of biological information. Broadly speaking, there are four types of activities that array data need to support. These include: (1) detection of patterns within the data from a single array by statistical techniques such as clustering; (2) comparison of patterns from multiple arrays; (3) linkage to related information in external databases; and (4) communication of data among collaborators and its transmission to private and public archives.
First generation computer programs for analysis of gene expression array data focused on pattern finding within the data values generated by one array, and the differential expression of genes using paired arrays. For these kinds of analyses, the most common format for organizing the data is a spreadsheet metaphor, usually with the genes of the array representing the rows and the columns representing experiments. Each intersection of row and column holds the expression value of a single position within the microarray (or in the case of GeneChips, a computed value such as the average difference between perfect match and mismatch probe sets 1 ). Viewed simply, the data are organized into a two-dimensional array that 2 use a spreadsheet model for the individual values of one or multiple array experiments. Simplicity is both the strength and weakness of this approach to array data handling, because as the number of data sources to be compared grows, they eventually exceed the capacity of spreadsheet programs to store and efficiently manipulate the data. More importantly, there are inevitably additional characteristics of each location in the microarray that need to be included in the analysis (eg, GeneChip absent-present calls) and the best representation of the information is an n-dimensional array (n Ͼ 2), which is difficult to represent using a spreadsheet metaphor.
As the volume of array experiments grows, so does the need to turn to a generalizable database approach to storing the data. The simplest approach to database design emulates the spreadsheet, with one record-pergene and the fields of the database record storing the same information that would be present in the row-column intersections of a spreadsheet. In this data model, additional experiments generally lead to the necessity to modify the unit record structure of the database, creating additional fields for gene expression values. This approach also eventually meets structural limitations of a database management system, such as a maximum number of Linkage of gene expression data to other online sources of information supports the biological interpretation of expression patterns. Examples include links to reference utilities, such as the GenBank, LocusLink, and GeneCard databases, 6 and metabolic pathway information. 7 The biomedical literature describing the function of genes is potentially a useful source of information to explain expression patterns, and recently developed prototype systems link gene names as contained in the titles and abstracts of the literature, 8 and the MEDLINE Medical Subject Heading keywords applied to articles describing genes 9 as the basis for determining possible similarities among genes that share common expression characteristics. In these cases, the key element from the expression experiment that links to the external source is generally a unique identifier for each gene contained on the array. These identifiers often include GenBank accession numbers, Unigene identifiers, and Human Genome Organization (HUGO) gene names. Maintaining lists of equivalence and similarity between the names of genes and gene probes present on microarrays, and the corresponding unique identifier present in various online databases, is a difficult but essential task for maximizing the usefulness of such linkages.
The greatest challenges in creating models for representing gene expression data come in the communication and sharing of data among different laboratories, and its submission to common archives in a format that describes the intent and experimental detail of the methods that produced each microarray's expression values. The benefit of a uniform set of characteristics for each experiment performed is substantial, including the ability to automatically merge data sets from different laboratories to gain statistical power, and perform meta-analysis of a variety of different experimental approaches. Achieving this goal is not easy.
Industry and academic groups are currently working toward standards to define both the minimum content and the structure for exchange of data sets containing gene expression data. The Microarray Gene Expression Database (MGED) 10 ) group is an international volunteer consortium devoted to developing standards for exchange of gene expression data. Their content standard, called 'Minimal Information About a Microarray Experiment' (MIAME) includes specifications for describing six elements of an array experiment, including experimental design, array design, samples used, hybridization procedures, measurements, and normalization methods.
For many types of pharmacogenomics investigations this information will be necessary but not sufficient, because the most interesting aspects of www.nature.com/tpj gene expression experiments are their correlations with clinical events and outcomes, which currently lie outside of the MIAME specification. Additionally, the issues of the naming of organisms, tissues, organ systems, and physiological effects that are essential to capturing the biological importance of microarray experiments are left unspecified in the standard.
A companion set of standards to MIAME is the structural format for exchange of gene expression data, which may be thought of as the 'electronic envelope' which contains the data as it is communicated over data networks. Gene Expression Markup Language and the Microarray Gene Expression Markup Language (MAGE ML) 11 for expression data and accompanying annotation and the Microarray are based on Extensible Markup Langauge (XML) tags developed specifically for microarray data. These standards are being developed by consortia that include laboratory instrument companies, and thus there is a reasonable hope that future gene expression measurement devices will be able to output data in a common format.
The volume and complexity of gene expression data produced by microarrays predicts that no single data model or standard will suffice for efficient local storage and analysis as well as for communication and sharing of the data. Thus, in the design of databases for storing gene expression data, flexibility to accommodate future change is in many cases the most important single characteristic of the ideal current system. Also, oligonucleotide and cDNA arrays are only the first widely employed sources of 'biological array' data; similar representation and analysis challenges will follow from proteomics and other laboratory methods that measure functional characteristics of thousands of biological molecules simultaneously. So adaptability is the order of the day for bioinformatics in support of gene expression analysis. Technology forecaster Alan Kay once noted, 'The best way to predict the future is to invent it.' The invention of optimal methods for storing, analyzing and communicating data in support of pharmacogenomics is a work in progress. 
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